Innovative Cancer Vaccine Strategies Based on the Identification of Tumour-Associated Antigens

Author： Ying H.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.12, 2001-01, pp. : 819-831

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically Modified Hepatitis B Surface Antigen: A Powerful Vaccine Technology for the Delivery of Disease-Associated Foreign Antigens

By  

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 226-234

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and 1-antitrypsin in patients with gastrointestinal malignancies

By Solakidi S.   Dessypris A.   Stathopoulos G.P.   Androulakis G.   Sekeris C.E.  

Clinical Biochemistry, Vol. 37, Iss. 1, 2004-01 ,pp. : 56-60

Elsevier

Access to resources Recommend Favorite

Adenoviral Vector-Based Strategies for Cancer Therapy

By  

Current Drug Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 117-138

Bentham Science Publishers

Access to resources Recommend Favorite

Mucosal Delivery of Vaccine by M Cell Targeting Strategies

By  

Current Drug Therapy, Vol. 9, Iss. 1, 2014-03 ,pp. : 9-20

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour Cell-Based Vaccines for the Treatment of Melanoma

By Hsueh E.C.  

BioDrugs, Vol. 15, Iss. 11, 2001-01 ,pp. : 713-720

Adis International

Access to resources Recommend Favorite